Taevas
ThailandMedical Devices
Product Registration
Market Access for Product-Registration in Thailand
Navigating the complexities of global regulatory landscapes and diverse payer environments is critical for successful product registration. Taevas Life Sciences provides comprehensive market access strategies to ensure your life sciences products achieve
Market
Global
Industry
Product-Registration
Regulator
International Regulatory Bodies
Timeline
8-12 weeks (initial assessment)
Deliverables
Strategy Report, Market Entry Roadmap, Value Dossier Framework
What We Deliver
6 Pillars of Market Access for Global Product Registration
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
01
Global Regulatory Intelligence & Landscape Analysis
We conduct in-depth analysis of diverse regulatory frameworks and market dynamics across target geographies. This ensures a clear understanding of requirements and potential hurdles before product registration.
Comprehensive country-specific regulatory reviews
Competitive landscape assessment
How It Works
How Our Global Market Access Process Works
A structured engagement — typically delivered in a few weeks.
Step 1 · Week 1-2
Initial Assessment & Strategic Blueprint
We begin with a thorough evaluation of your product, target markets, and existing data. This forms the foundation for a customized market access blueprint, outlining key objectives and deliverables.
Market Snapshot
Market Overview: Global Product-Registration & Market Access
Regulatory Divergence & Harmonization Challenges
The absence of a single global regulatory body necessitates navigating diverse and often conflicting requirements, demanding highly specialized expertise for successful product registration and market access.
Escalating Payer Scrutiny & Value Demands
Global payers are increasingly demanding robust clinical and economic evidence to justify product pricing and reimbursement, shifting focus from efficacy alone to comprehensive value demonstration.
Importance of Early Market Access Strategy
Integrating market access considerations early in product development is critical. Proactive planning can significantly reduce time-to-market and maximize commercial potential across multiple geographies.
What's Included
Deliverables
A structured, decision-ready package of deliverables.
Comprehensive Global Market Access Strategy Report
A detailed roadmap outlining target markets, regulatory pathways, HTA requirements, and strategic recommendations for successful product registration and access.
Payer & HTA Value Dossier Framework
A structured framework for developing compelling value propositions and evidence packages tailored to the specific needs of global payers and Health Technology Assessment bodies.
Global Pricing & Reimbursement Blueprint
An actionable plan detailing optimal pricing strategies, reimbursement models, and negotiation tactics for key international markets.
Stakeholder Engagement & Advocacy Plan
A strategic plan for identifying, engaging, and advocating with critical regulatory, payer, and medical stakeholders worldwide.
Who This Is For
Use Cases
Novel Therapeutic Launch
Accelerating a Novel Oncology Drug to Global Markets
A biotech company with a breakthrough oncology drug needed to secure rapid market access across North America, Europe, and Asia-Pacific. Taevas developed a synchronized global strategy, managing diverse regulatory submissions and HTA requirements.
Outcome
Achieved market registration and favorable reimbursement in multiple key markets within 18 months, significantly reducing time-to-patient.
Next Steps
Related Services
FAQ
Frequently Asked Questions
Get Started
Ready to Secure Global Market Access for Your Product?
Partner with Taevas Life Sciences to transform complex global market access challenges into strategic advantages. Our expert team is prepared to guide your product to successful registration and commercialization worldwide.
Accelerated Time-to-Market
Optimized Pricing & Reimbursement
Reduced Regulatory Risk
Maximized Commercial Potential